Anjali LabTech IPO: Valuation Analysis, Sector Peer Benchmarks & What to Watch

MUMBAI / NEW DELHI, SEPTEMBER 25, 2026 — During trading on Friday, September 25, 2026, lab-grown diamond manufacturer Anjali LabTech Ltd officially re-submitted its updated draft red herring prospectus (DRHP) to the Securities and Exchange Board of India (SEBI) for an initial public offering targeting ₹1,225 crore, according to regulatory filings reported by The Economic Times.

The proposed public issue comprises a fresh capital raising of ₹925 crore alongside an Offer For Sale (OFS) component by existing promoter shareholders. Furthermore, corporate disclosures indicate that Anjali LabTech is exploring a pre-IPO placement round to aggregate up to ₹185 crore prior to the finalization of the red herring prospectus. Net proceeds from the fresh issue are earmarked toward funding capital expenditure requirements for manufacturing expansion and general corporate purposes.

Key Issue Details & Financial Parameters

Key Dates & Timeline Calendar

Grey Market Premium (GMP) Tracking Status

As Anjali LabTech has only just re-submitted its updated draft papers to SEBI on September 25, 2026, the public issue is in the preliminary regulatory clearance phase. GMP data is pending initial price discovery across primary tracking platforms (Chittorgarh & IPOWatch). Institutional analysts and retail investors should monitor forthcoming announcements regarding price band finalization.

In-Depth Analysis: The Lab-Grown Diamond Sector Opportunity

According to market research compiled by sector analysts, the Indian lab-grown diamond (LGD) manufacturing segment is witnessing accelerated adoption due to shifting consumer preferences toward sustainable, eco-friendly luxury goods and cost-efficient alternatives to mined diamonds. Filings submitted to BSE and NSE India confirm that capital allocation from the ₹925 crore fresh issue will strengthen technological infrastructure.

Capital Deployment & Pre-IPO Strategy

Brokerage notes highlight that the planned pre-IPO placement of up to ₹185 crore will assist in moderating overall dilution for existing shareholders prior to public price discovery. Fundamental metrics from financial databases like Screener.in and Trendlyne will provide granular insights into return on capital employed (ROCE) and EBITDA margins once the updated financial statements are formally unlocked in the final RHP.

Investor Framework: Bull vs. Bear Catalysts

Growth Catalysts (Bull Case)

• Secular Industry Tailwinds: Rapid global and domestic escalation in lab-grown diamond jewellery demand.
• Balance Sheet Strengthening: Fresh issue proceeds of ₹925 crore directly improve internal liquidity and fund capital expenditure.
• Strategic Pre-IPO Funding: Potential ₹185 crore pre-IPO placement validates institutional interest.

Key Downside Risks (Bear Case)

• Pricing Volatility: Fluctuations in international rough and polished lab-grown diamond realisations.
• Promoter Selling: Presence of an OFS component means partial promoter dilution upon listing.

Frequently Asked Questions

What should investors check before applying for Anjali LabTech IPO shares based on valuations?

Valuation metrics and price bands are currently pending formal RHP disclosure following the September 25, 2026 SEBI re-filing. Investors should evaluate financial multiples against sector peers once pricing details are published.

What is the Grey Market Premium (GMP) and expected listing sentiment for Anjali LabTech?

GMP data is pending initial price discovery across primary tracking platforms (Chittorgarh & IPOWatch) as the IPO is in early regulatory filing stages.

What are the primary balance sheet strengths and risk factors for Anjali LabTech?

The primary balance sheet catalyst is the infusion of ₹925 crore in fresh capital expenditure funds, while key risks involve commodity price fluctuations in the lab-grown diamond sector.

Sources referenced: Chittorgarh, Moneycontrol, The Economic Times Markets Feed, BSE India filings, Screener.in

Reusing this article or its images? Credit IPO Bulletin and link to https://ipobulletin.com/2026/09/anjali-labtech-ipo-valuation-analysis-sector-peer-benchmarks-what-to-watch.html. Content licence.